Trial intelligence / Profile preview

Gliclazide MR capsule vs gliclazide tablet in type 2 diabetes

CTR20130123Phase 3Completed

Sponsor
Beishi Pharma
Start
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of gliclazide in type 2 diabetes mellitus (T2DM), sponsored by Beishi Pharma. Started Jan 2014; status: completed.

02

Drugs

gliclazide
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on CTR20130123.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130123.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call